EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers

Martina Lombardi, Jacopo Troisi, Benedetta Maria Motta iD, Pietro Torre, Mario Masarone iD, Marcello Persico iD

Nutrients · 2024

DOI: 10.3390/nu16071025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Martina Lombardi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biology "A. Zambelli", University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, SA, Italy. Hauptthemen laut MEDLINE: Hypertension, Portal, Gastrointestinal Microbiome, Liver, Dysbiosis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Portal hypertension (PH) is a complex clinical challenge with severe complications, including variceal bleeding, ascites, hepatic encephalopathy, and hepatorenal syndrome. The gut microbiota (GM) and its interconnectedness with human health have emerged as a captivating field of research. This review explores the intricate connections between the gut and the liver, aiming to elucidate how alterations in GM, intestinal barrier function, and gut-derived molecules impact the development and progression of PH. A systematic literature search, following PRISMA guidelines, identified 12 original articles that suggest a relationship between GM, the gut–liver axis, and PH. Mechanisms such as dysbiosis, bacterial translocation, altered microbial structure, and inflammation appear to orchestrate this relationship. One notable study highlights the pivotal role of the farnesoid X receptor axis in regulating the interplay between the gut and liver and proposes it as a promising therapeutic target. Fecal transplantation experiments further emphasize the pathogenic significance of the GM in modulating liver maladies, including PH. Recent advancements in metagenomics and metabolomics have expanded our understanding of the GM’s role in human ailments. The review suggests that addressing the unmet need of identifying gut–liver axis-related metabolic and molecular pathways holds potential for elucidating pathogenesis and directing novel therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PortalGastrointestinal MicrobiomeLiverDysbiosisHumansBacterial TranslocationAnimalsFecal Microbiota Transplantation

Stichwörter der Autor:innen

gut–liver axisliver diseasesmetabolomicsmicrobiomeportal hypertension

Autor:innen und Institutionen

  • Department of Chemistry and Biology "A. Zambelli", University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, SA, Italy.
  • European Institute of Metabolomics (EIM) Foundation, Via G. Puccini, 3, 84081 Baronissi, SA, Italy.
  • Department of Medicine, Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, SA, Italy.

ORCID-Profile: Benedetta Maria Motta, Mario Masarone, Marcello Persico

Zitieren

APA

Lombardi, M., Troisi, J., Motta, B. M., Torre, P., Masarone, M., & Persico, M. (2024). Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers. Nutrients. https://doi.org/10.3390/nu16071025

Vancouver

Lombardi M, Troisi J, Motta BM, Torre P, Masarone M, Persico M. Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers. Nutrients. 2024. doi:10.3390/nu16071025

BibTeX
@article{Lombardi2024,
  author = {Lombardi, Martina and Troisi, Jacopo and Motta, Benedetta Maria and Torre, Pietro and Masarone, Mario and Persico, Marcello},
  title = {Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16071025}
}
Kostenlos starten →